Technology News and Research

RSS

Scientists develop nano-sized vehicle to deliver chemotherapy drugs directly into cancer cells

Chemotherapy, while an effective cancer treatment, also brings debilitating side effects such as nausea, liver toxicity and a battered immune system.Now, a new way to deliver this life-saving therapy to cancer patients getting straight to the source of the disease.

24 Aug 2010

Today's opinions: More on the trustee's report, cutting the deficit

Republicans claim to be deeply worried about the deficit — their favorite political target, followed closely by President Obama's relentlessly demonized health care reform. So why are they so determined to overturn one of the central cost-control mechanisms of the new reform law? (8/21).

23 Aug 2010

SEB opens new state-of-the-art laboratory operation, R&D facility

Cryo-Cell International, Inc., one of the largest and most established leaders in stem cell innovation today announced that S-Evans Biosciences, the Company's exclusive Célle menstrual stem cell technology license partner in China has opened a new state-of-the-art laboratory operation and research & development facility located in a Hi-Tech park designated to become an epicenter for stem cell and genomics R&D; cellular therapies and stem cell cryopreservation services.

23 Aug 2010

Preclinical studies of BIND-014 to be presented at ACS National Meeting

BIND Biosciences announced today the presentation of its Medicinal Nanoengineering platform at the ACS National Meeting, including results from preclinical studies on its lead nanomedicine drug , BIND-014, scheduled to enter clinical trials later this year. BIND-014 is a targeted, polymeric nanoparticle containing the cytotoxic agent, docetaxel, which is approved in major cancer indications, including breast, prostate and lung.

23 Aug 2010

Svelte Medical Systems secures CE Mark to distribute Acrobat SOAW stenting system in the European Union

Svelte Medical Systems, Inc. is pleased to announce that it has officially received the CE Mark to market its Acrobat Stent-on-a-Wire Bare Metal Coronary Stent System in the European Union. The Acrobat SOAW stenting system has been shown in clinical trials to facilitate direct stenting and has the potential to provide substantial procedural time and cost savings.

23 Aug 2010

Taligen Therapeutics announces closing on $10M tranche of Series B financing

Taligen Therapeutics, a biotechnology company developing therapies that regulate the complement system to treat inflammatory and immune diseases, today announced that it has closed on a $10 million tranche of a Series B financing, based on substantial progress with the company's product pipeline including advancing the lead product candidate, TT30, toward clinical development.

23 Aug 2010

Applied Biosystems 3500 Dx Series Genetic Analyzers now available in Asia Pacific Region

Life Technologies Corporation today announced that its Applied Biosystems 3500 Dx Series Genetic Analyzers, the first CE IVD-marked capillary electrophoresis system for nucleic acid analysis, are now available for sale in Australia, India, New Zealand, Singapore, and Taiwan.

23 Aug 2010

InSite Vision initiates Phase 1/2 clinical trial of ISV-303

InSite Vision Incorporated, a company developing novel ophthalmic therapeutics, today announced the initiation of a Phase 1/2 clinical trial of ISV-303, a topical anti-inflammatory product intended to reduce the pain and inflammation associated with ocular surgery. ISV-303 combines a low dose of the non-steroidal anti-inflammatory bromfenac with InSite Vision's proprietary DuraSite technology.

23 Aug 2010

Arrayit selects PMA pathway for OvaDx Pre-Symptomatic Ovarian Cancer Screening Test

Arrayit Corporation, a leader in life sciences and healthcare technology, announces today that the company has chosen the Premarket Approval pathway for its OvaDx Pre-Symptomatic Ovarian Cancer Screening Test. While the standard for a PMA is higher than for a 510(k), the company believes that a PMA OvaDx submission can achieve a Class III PMA approval, the most stringent approval level granted by the FDA for in vitro diagnostic devices.

23 Aug 2010

First Edition: Aug. 23, 2010

Today's headlines include news about developments related to the nation's medical privacy rules and the power struggle surrounding implementation regulations for a key section of the new health law.

23 Aug 2010

MedClean technologies second quarter 2010 revenue decreases to $131,758

MedClean Technologies, Inc., the leading provider of on-site technology for the treatment and disposal of medical waste and the destruction of confidential documents and related media, today announced financial results for the 2010 second quarter for the period ended June 30, 2010.

23 Aug 2010

TAP installs CompacT SelecT culture system at US biodefence campus to produce high quality cell lines

The Automation Partnership (TAP), a world leader in the design and development of innovative automation for life science applications, today announced CompacT SelecT™ automated cell culture system is being installed at a prestigious, new US defence facility, to produce high quality cell lines in containment conditions.

23 Aug 2010

NextGen Healthcare collaborates with clients for Primary Care Information Project

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, today announced its successful collaboration with clients that received assistance through the Primary Care Information Project (PCIP), a bureau of the NYC Health Department.

23 Aug 2010

Samplify receives second series of patent for medical imaging applications

Samplify Systems, Inc., a leading provider of signal-compression technology, semiconductors, and solutions, today announced that the Chinese Government has granted the company its second series of technology patents for medical imaging applications. These new patents come on the heels of the first series of patents that were granted earlier this month for wireless base station compression.

23 Aug 2010

Scientists develop new synthetic material to grow stem cells

Human pluripotent stem cells, which can become any other kind of body cell, hold great potential to treat a wide range of ailments, including Parkinson's disease, multiple sclerosis and spinal cord injuries. However, scientists who work with such cells have had trouble growing large enough quantities to perform experiments - in particular, to be used in human studies. Furthermore, most materials now used to grow human stem cells include cells or proteins that come from mice embryos, which help stimulate stem-cell growth but would likely cause an immune reaction if injected into a human patient.

23 Aug 2010

Martin Karplus receives 2010 Russell Varian Prize for NMR innovation

Agilent Technologies Inc. announced Martin Karplus, professor emeritus, Department of Chemistry and Chemical Biology, Harvard University; and Laboratoire de Chimie Biophysique, ISIS, Université Louis Pasteur, the winner of the 2010 Russell Varian Prize.

23 Aug 2010

New diagnostic tool proves cost-effective in identifying rare genetic disorders

Mutations in a single gene can cause several types of developmental brain abnormalities that experts have traditionally considered different disorders. With support from the National Institutes of Health, researchers found those mutations through whole exome sequencing - a new gene scanning technology that cuts the cost and time of searching for rare mutations.

23 Aug 2010

NBA player Alonzo Mourning uses celebrity fame to fight kidney disease

In October 2000, Mourning was diagnosed with focal segmental glomerular sclerosis (FSGS), a kidney disease that causes scarring in the glomeruli, the blood vessels in the kidneys that filter the blood to make urine.

21 Aug 2010

Revolutions Medical announces details on MRI paper presentation at IPCV

Revolutions Medical Corporation announces additional details regarding clinical studies and presentation of related MRI paper at IPCV (Image Processing and Computer Vision) by H. Keith Brown, PhD.

21 Aug 2010

Donors announce new pledges for Pakistan flood relief

The U.S. and other donor nations "significantly upped their pledges" of aid for the flooding in Pakistan during a U.N. General Assembly meeting on Thursday, in which the U.N. "appeared to [meet] its target of $460 million in immediate aid for flood-stricken Pakistan," the Associated Press reports.

21 Aug 2010